Global Breast Cancer Monoclonal Antibodies Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	182 Pages	TechNavio	July, 2024	INF19033919

Best Price Guarantee
Price	from $2,500
Length	182 Pages
Publisher	TechNavio
Published Date	July, 2024
SKU	INF19033919

Global Breast Cancer Monoclonal Antibodies Market 2024-2028

The breast Cancer monoclonal antibodies market is forecasted to grow by USD 19.2 bn during 2023-2028, accelerating at a CAGR of 13.97% during the forecast period. The report on the breast Cancer monoclonal antibodies market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of breast Cancer, rising number of patient support initiatives for breast Cancer awareness, and increasing demand for minimally invasive therapies for breast Cancer treatment.

Technavio's breast Cancer monoclonal antibodies market is segmented as below:

By End-user

Hospitals
Research institutes
Others

By Type

Humanized
Human
Chimeric
Murine

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increase in number of product approvals and expanded product pipeline as one of the prime reasons driving the breast Cancer monoclonal antibodies market growth during the next few years. Also, growing number of strategic collaborations and increasing focus on breast Cancer diagnosis and treatment in emerging economies will lead to sizable demand in the market.

The report on the breast Cancer monoclonal antibodies market covers the following areas:

Breast Cancer monoclonal antibodies market sizing
Breast Cancer monoclonal antibodies market forecast
Breast Cancer monoclonal antibodies market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading breast Cancer monoclonal antibodies market vendors that include Amgen Inc., AstraZeneca PLC, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Celldex Therapeutics Inc, Celltrion Co. Ltd., Daiichi Sankyo Co. Ltd., Eisai Co. Ltd., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., Johnson and Johnson Services Inc., MacroGenics Inc., Merck KGaA, Novartis AG, Pfizer Inc., Puma Biotechnology Inc., Sanofi SA, Seagen Inc., Teva Pharmaceutical Industries Ltd., and Viatris Inc.. Also, the breast Cancer monoclonal antibodies market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by End-user; Executive Summary - Chart on Market Segmentation by Type; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ billion); Data Table on Global - Market size and forecast 2023-2028 ($ billion); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global Breast Cancer Monoclonal Antibodies Market 2018 - 2022; Historic Market Size - Data Table on Global Breast Cancer Monoclonal Antibodies Market 2018 - 2022 ($ billion); 4.2 End-user segment analysis 2018 - 2022; Historic Market Size - End-user Segment 2018 - 2022 ($ billion); 4.3 Type segment analysis 2018 - 2022; Historic Market Size - Type Segment 2018 - 2022 ($ billion); 4.4 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ billion); 4.5 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user: 6.1 Market segments; Chart on End-user - Market share 2023-2028 (%); Data Table on End-user - Market share 2023-2028 (%); 6.2 Comparison by End-user; Chart on Comparison by End-user; Data Table on Comparison by End-user; 6.3 Hospitals - Market size and forecast 2023-2028; Chart on Hospitals - Market size and forecast 2023-2028 ($ billion); Data Table on Hospitals - Market size and forecast 2023-2028 ($ billion); Chart on Hospitals - Year-over-year growth 2023-2028 (%); Data Table on Hospitals - Year-over-year growth 2023-2028 (%); 6.4 Research institutes - Market size and forecast 2023-2028; Chart on Research institutes - Market size and forecast 2023-2028 ($ billion); Data Table on Research institutes - Market size and forecast 2023-2028 ($ billion); Chart on Research institutes - Year-over-year growth 2023-2028 (%); Data Table on Research institutes - Year-over-year growth 2023-2028 (%); 6.5 Others - Market size and forecast 2023-2028; Chart on Others - Market size and forecast 2023-2028 ($ billion); Data Table on Others - Market size and forecast 2023-2028 ($ billion); Chart on Others - Year-over-year growth 2023-2028 (%); Data Table on Others - Year-over-year growth 2023-2028 (%); 6.6 Market opportunity by End-user; Market opportunity by End-user ($ billion); Data Table on Market opportunity by End-user ($ billion)
7 Market Segmentation by Type: 7.1 Market segments; Chart on Type - Market share 2023-2028 (%); Data Table on Type - Market share 2023-2028 (%); 7.2 Comparison by Type; Chart on Comparison by Type; Data Table on Comparison by Type; 7.3 Humanized - Market size and forecast 2023-2028; Chart on Humanized - Market size and forecast 2023-2028 ($ billion); Data Table on Humanized - Market size and forecast 2023-2028 ($ billion); Chart on Humanized - Year-over-year growth 2023-2028 (%); Data Table on Humanized - Year-over-year growth 2023-2028 (%); 7.4 Human - Market size and forecast 2023-2028; Chart on Human - Market size and forecast 2023-2028 ($ billion); Data Table on Human - Market size and forecast 2023-2028 ($ billion); Chart on Human - Year-over-year growth 2023-2028 (%); Data Table on Human - Year-over-year growth 2023-2028 (%); 7.5 Chimeric - Market size and forecast 2023-2028; Chart on Chimeric - Market size and forecast 2023-2028 ($ billion); Data Table on Chimeric - Market size and forecast 2023-2028 ($ billion); Chart on Chimeric - Year-over-year growth 2023-2028 (%); Data Table on Chimeric - Year-over-year growth 2023-2028 (%); 7.6 Murine - Market size and forecast 2023-2028; Chart on Murine - Market size and forecast 2023-2028 ($ billion); Data Table on Murine - Market size and forecast 2023-2028 ($ billion); Chart on Murine - Year-over-year growth 2023-2028 (%); Data Table on Murine - Year-over-year growth 2023-2028 (%); 7.7 Market opportunity by Type; Market opportunity by Type ($ billion); Data Table on Market opportunity by Type ($ billion)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2023-2028 (%); Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ billion); Data Table on North America - Market size and forecast 2023-2028 ($ billion); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ billion); Data Table on Europe - Market size and forecast 2023-2028 ($ billion); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ billion); Data Table on Asia - Market size and forecast 2023-2028 ($ billion); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ billion); Data Table on US - Market size and forecast 2023-2028 ($ billion); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 France - Market size and forecast 2023-2028; Chart on France - Market size and forecast 2023-2028 ($ billion); Data Table on France - Market size and forecast 2023-2028 ($ billion); Chart on France - Year-over-year growth 2023-2028 (%); Data Table on France - Year-over-year growth 2023-2028 (%); 9.9 China - Market size and forecast 2023-2028; Chart on China - Market size and forecast 2023-2028 ($ billion); Data Table on China - Market size and forecast 2023-2028 ($ billion); Chart on China - Year-over-year growth 2023-2028 (%); Data Table on China - Year-over-year growth 2023-2028 (%); 9.10 The Netherlands - Market size and forecast 2023-2028; Chart on The Netherlands - Market size and forecast 2023-2028 ($ billion); Data Table on The Netherlands - Market size and forecast 2023-2028 ($ billion); Chart on The Netherlands - Year-over-year growth 2023-2028 (%); Data Table on The Netherlands - Year-over-year growth 2023-2028 (%); 9.11 Canada - Market size and forecast 2023-2028; Chart on Canada - Market size and forecast 2023-2028 ($ billion); Data Table on Canada - Market size and forecast 2023-2028 ($ billion); Chart on Canada - Year-over-year growth 2023-2028 (%); Data Table on Canada - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ billion); Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Opportunity/Restraints: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 10.4 Market opportunities/restraints
11 Competitive Landscape: 11.1 Overview; 11.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 11.3 Landscape disruption; Overview on factors of disruption; 11.4 Industry risks; Impact of key risks on business
12 Competitive Analysis: 12.1 Companies profiled; Companies covered; 12.2 Market positioning of companies; Matrix on companies position and classification; 12.3 Amgen Inc.; Amgen Inc. - Overview; Amgen Inc. - Product / Service; Amgen Inc. - Key news; Amgen Inc. - Key offerings; 12.4 AstraZeneca Plc; AstraZeneca Plc - Overview; AstraZeneca Plc - Product / Service; AstraZeneca Plc - Key news; AstraZeneca Plc - Key offerings; 12.5 Boehringer Ingelheim International GmbH; Boehringer Ingelheim International GmbH - Overview; Boehringer Ingelheim International GmbH - Product / Service; Boehringer Ingelheim International GmbH - Key news; Boehringer Ingelheim International GmbH - Key offerings; 12.6 Bristol Myers Squibb Co.; Bristol Myers Squibb Co. - Overview; Bristol Myers Squibb Co. - Product / Service; Bristol Myers Squibb Co. - Key news; Bristol Myers Squibb Co. - Key offerings; 12.7 Celldex Therapeutics Inc; Celldex Therapeutics Inc - Overview; Celldex Therapeutics Inc - Product / Service; Celldex Therapeutics Inc - Key offerings; 12.8 Daiichi Sankyo Co. Ltd.; Daiichi Sankyo Co. Ltd. - Overview; Daiichi Sankyo Co. Ltd. - Product / Service; Daiichi Sankyo Co. Ltd. - Key news; Daiichi Sankyo Co. Ltd. - Key offerings; 12.9 F. Hoffmann La Roche Ltd.; F. Hoffmann La Roche Ltd. - Overview; F. Hoffmann La Roche Ltd. - Business segments; F. Hoffmann La Roche Ltd. - Key news; F. Hoffmann La Roche Ltd. - Key offerings; F. Hoffmann La Roche Ltd. - Segment focus; 12.10 Gilead Sciences Inc.; Gilead Sciences Inc. - Overview; Gilead Sciences Inc. - Product / Service; Gilead Sciences Inc. - Key news; Gilead Sciences Inc. - Key offerings; 12.11 Johnson and Johnson Services Inc.; Johnson and Johnson Services Inc. - Overview; Johnson and Johnson Services Inc. - Business segments; Johnson and Johnson Services Inc. - Key news; Johnson and Johnson Services Inc. - Key offerings; Johnson and Johnson Services Inc. - Segment focus; 12.12 MacroGenics Inc.; MacroGenics Inc. - Overview; MacroGenics Inc. - Product / Service; MacroGenics Inc. - Key offerings; 12.13 Merck KGaA; Merck KGaA - Overview; Merck KGaA - Business segments; Merck KGaA - Key news; Merck KGaA - Key offerings; Merck KGaA - Segment focus; 12.14 Novartis AG; Novartis AG - Overview; Novartis AG - Business segments; Novartis AG - Key news; Novartis AG - Key offerings; Novartis AG - Segment focus; 12.15 Pfizer Inc.; Pfizer Inc. - Overview; Pfizer Inc. - Product / Service; Pfizer Inc. - Key news; Pfizer Inc. - Key offerings; 12.16 Sanofi SA; Sanofi SA - Overview; Sanofi SA - Business segments; Sanofi SA - Key news; Sanofi SA - Key offerings; Sanofi SA - Segment focus; 12.17 Viatris Inc.; Viatris Inc. - Overview; Viatris Inc. - Business segments; Viatris Inc. - Key news; Viatris Inc. - Key offerings; Viatris Inc. - Segment focus
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 13.3 Currency conversion rates for US$; Currency conversion rates for US$; 13.4 Research methodology; Research methodology; 13.5 Data procurement; Information sources; 13.6 Data validation; Data validation; 13.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 13.8 Data synthesis; Data synthesis; 13.9 360 degree market analysis; 360 degree market analysis; 13.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by End-user; Exhibits6: Executive Summary - Chart on Market Segmentation by Type; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Parent Market; Exhibits11: Data Table on - Parent Market; Exhibits12: Market characteristics analysis; Exhibits13: Value Chain Analysis; Exhibits14: Offerings of companies included in the market definition; Exhibits15: Market segments; Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ billion); Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ billion); Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits20: Historic Market Size - Data Table on Global Breast Cancer Monoclonal Antibodies Market 2018 - 2022 ($ billion); Exhibits21: Historic Market Size - End-user Segment 2018 - 2022 ($ billion); Exhibits22: Historic Market Size - Type Segment 2018 - 2022 ($ billion); Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ billion); Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ billion); Exhibits25: Five forces analysis - Comparison between 2023 and 2028; Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits31: Chart on Market condition - Five forces 2023 and 2028; Exhibits32: Chart on End-user - Market share 2023-2028 (%); Exhibits33: Data Table on End-user - Market share 2023-2028 (%); Exhibits34: Chart on Comparison by End-user; Exhibits35: Data Table on Comparison by End-user; Exhibits36: Chart on Hospitals - Market size and forecast 2023-2028 ($ billion); Exhibits37: Data Table on Hospitals - Market size and forecast 2023-2028 ($ billion); Exhibits38: Chart on Hospitals - Year-over-year growth 2023-2028 (%); Exhibits39: Data Table on Hospitals - Year-over-year growth 2023-2028 (%); Exhibits40: Chart on Research institutes - Market size and forecast 2023-2028 ($ billion); Exhibits41: Data Table on Research institutes - Market size and forecast 2023-2028 ($ billion); Exhibits42: Chart on Research institutes - Year-over-year growth 2023-2028 (%); Exhibits43: Data Table on Research institutes - Year-over-year growth 2023-2028 (%); Exhibits44: Chart on Others - Market size and forecast 2023-2028 ($ billion); Exhibits45: Data Table on Others - Market size and forecast 2023-2028 ($ billion); Exhibits46: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibits47: Data Table on Others - Year-over-year growth 2023-2028 (%); Exhibits48: Market opportunity by End-user ($ billion); Exhibits49: Data Table on Market opportunity by End-user ($ billion); Exhibits50: Chart on Type - Market share 2023-2028 (%); Exhibits51: Data Table on Type - Market share 2023-2028 (%); Exhibits52: Chart on Comparison by Type; Exhibits53: Data Table on Comparison by Type; Exhibits54: Chart on Humanized - Market size and forecast 2023-2028 ($ billion); Exhibits55: Data Table on Humanized - Market size and forecast 2023-2028 ($ billion); Exhibits56: Chart on Humanized - Year-over-year growth 2023-2028 (%); Exhibits57: Data Table on Humanized - Year-over-year growth 2023-2028 (%); Exhibits58: Chart on Human - Market size and forecast 2023-2028 ($ billion); Exhibits59: Data Table on Human - Market size and forecast 2023-2028 ($ billion); Exhibits60: Chart on Human - Year-over-year growth 2023-2028 (%); Exhibits61: Data Table on Human - Year-over-year growth 2023-2028 (%); Exhibits62: Chart on Chimeric - Market size and forecast 2023-2028 ($ billion); Exhibits63: Data Table on Chimeric - Market size and forecast 2023-2028 ($ billion); Exhibits64: Chart on Chimeric - Year-over-year growth 2023-2028 (%); Exhibits65: Data Table on Chimeric - Year-over-year growth 2023-2028 (%); Exhibits66: Chart on Murine - Market size and forecast 2023-2028 ($ billion); Exhibits67: Data Table on Murine - Market size and forecast 2023-2028 ($ billion); Exhibits68: Chart on Murine - Year-over-year growth 2023-2028 (%); Exhibits69: Data Table on Murine - Year-over-year growth 2023-2028 (%); Exhibits70: Market opportunity by Type ($ billion); Exhibits71: Data Table on Market opportunity by Type ($ billion); Exhibits72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits73: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits74: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits75: Chart on Geographic comparison; Exhibits76: Data Table on Geographic comparison; Exhibits77: Chart on North America - Market size and forecast 2023-2028 ($ billion); Exhibits78: Data Table on North America - Market size and forecast 2023-2028 ($ billion); Exhibits79: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits81: Chart on Europe - Market size and forecast 2023-2028 ($ billion); Exhibits82: Data Table on Europe - Market size and forecast 2023-2028 ($ billion); Exhibits83: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits85: Chart on Asia - Market size and forecast 2023-2028 ($ billion); Exhibits86: Data Table on Asia - Market size and forecast 2023-2028 ($ billion); Exhibits87: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits88: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits89: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Exhibits90: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Exhibits91: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits92: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits93: Chart on US - Market size and forecast 2023-2028 ($ billion); Exhibits94: Data Table on US - Market size and forecast 2023-2028 ($ billion); Exhibits95: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits96: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits97: Chart on France - Market size and forecast 2023-2028 ($ billion); Exhibits98: Data Table on France - Market size and forecast 2023-2028 ($ billion); Exhibits99: Chart on France - Year-over-year growth 2023-2028 (%); Exhibits100: Data Table on France - Year-over-year growth 2023-2028 (%); Exhibits101: Chart on China - Market size and forecast 2023-2028 ($ billion); Exhibits102: Data Table on China - Market size and forecast 2023-2028 ($ billion); Exhibits103: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits104: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits105: Chart on The Netherlands - Market size and forecast 2023-2028 ($ billion); Exhibits106: Data Table on The Netherlands - Market size and forecast 2023-2028 ($ billion); Exhibits107: Chart on The Netherlands - Year-over-year growth 2023-2028 (%); Exhibits108: Data Table on The Netherlands - Year-over-year growth 2023-2028 (%); Exhibits109: Chart on Canada - Market size and forecast 2023-2028 ($ billion); Exhibits110: Data Table on Canada - Market size and forecast 2023-2028 ($ billion); Exhibits111: Chart on Canada - Year-over-year growth 2023-2028 (%); Exhibits112: Data Table on Canada - Year-over-year growth 2023-2028 (%); Exhibits113: Market opportunity By Geographical Landscape ($ billion); Exhibits114: Data Tables on Market opportunity By Geographical Landscape ($ billion); Exhibits115: Impact of drivers and challenges in 2023 and 2028; Exhibits116: Overview on criticality of inputs and factors of differentiation; Exhibits117: Overview on factors of disruption; Exhibits118: Impact of key risks on business; Exhibits119: Companies covered; Exhibits120: Matrix on companies position and classification; Exhibits121: Amgen Inc. - Overview; Exhibits122: Amgen Inc. - Product / Service; Exhibits123: Amgen Inc. - Key news; Exhibits124: Amgen Inc. - Key offerings; Exhibits125: AstraZeneca Plc - Overview; Exhibits126: AstraZeneca Plc - Product / Service; Exhibits127: AstraZeneca Plc - Key news; Exhibits128: AstraZeneca Plc - Key offerings; Exhibits129: Boehringer Ingelheim International GmbH - Overview; Exhibits130: Boehringer Ingelheim International GmbH - Product / Service; Exhibits131: Boehringer Ingelheim International GmbH - Key news; Exhibits132: Boehringer Ingelheim International GmbH - Key offerings; Exhibits133: Bristol Myers Squibb Co. - Overview; Exhibits134: Bristol Myers Squibb Co. - Product / Service; Exhibits135: Bristol Myers Squibb Co. - Key news; Exhibits136: Bristol Myers Squibb Co. - Key offerings; Exhibits137: Celldex Therapeutics Inc - Overview; Exhibits138: Celldex Therapeutics Inc - Product / Service; Exhibits139: Celldex Therapeutics Inc - Key offerings; Exhibits140: Daiichi Sankyo Co. Ltd. - Overview; Exhibits141: Daiichi Sankyo Co. Ltd. - Product / Service; Exhibits142: Daiichi Sankyo Co. Ltd. - Key news; Exhibits143: Daiichi Sankyo Co. Ltd. - Key offerings; Exhibits144: F. Hoffmann La Roche Ltd. - Overview; Exhibits145: F. Hoffmann La Roche Ltd. - Business segments; Exhibits146: F. Hoffmann La Roche Ltd. - Key news; Exhibits147: F. Hoffmann La Roche Ltd. - Key offerings; Exhibits148: F. Hoffmann La Roche Ltd. - Segment focus; Exhibits149: Gilead Sciences Inc. - Overview; Exhibits150: Gilead Sciences Inc. - Product / Service; Exhibits151: Gilead Sciences Inc. - Key news; Exhibits152: Gilead Sciences Inc. - Key offerings; Exhibits153: Johnson and Johnson Services Inc. - Overview; Exhibits154: Johnson and Johnson Services Inc. - Business segments; Exhibits155: Johnson and Johnson Services Inc. - Key news; Exhibits156: Johnson and Johnson Services Inc. - Key offerings; Exhibits157: Johnson and Johnson Services Inc. - Segment focus; Exhibits158: MacroGenics Inc. - Overview; Exhibits159: MacroGenics Inc. - Product / Service; Exhibits160: MacroGenics Inc. - Key offerings; Exhibits161: Merck KGaA - Overview; Exhibits162: Merck KGaA - Business segments; Exhibits163: Merck KGaA - Key news; Exhibits164: Merck KGaA - Key offerings; Exhibits165: Merck KGaA - Segment focus; Exhibits166: Novartis AG - Overview; Exhibits167: Novartis AG - Business segments; Exhibits168: Novartis AG - Key news; Exhibits169: Novartis AG - Key offerings; Exhibits170: Novartis AG - Segment focus; Exhibits171: Pfizer Inc. - Overview; Exhibits172: Pfizer Inc. - Product / Service; Exhibits173: Pfizer Inc. - Key news; Exhibits174: Pfizer Inc. - Key offerings; Exhibits175: Sanofi SA - Overview; Exhibits176: Sanofi SA - Business segments; Exhibits177: Sanofi SA - Key news; Exhibits178: Sanofi SA - Key offerings; Exhibits179: Sanofi SA - Segment focus; Exhibits180: Viatris Inc. - Overview; Exhibits181: Viatris Inc. - Business segments; Exhibits182: Viatris Inc. - Key news; Exhibits183: Viatris Inc. - Key offerings; Exhibits184: Viatris Inc. - Segment focus; Exhibits185: Inclusions checklist; Exhibits186: Exclusions checklist; Exhibits187: Currency conversion rates for US$; Exhibits188: Research methodology; Exhibits189: Information sources; Exhibits190: Data validation; Exhibits191: Validation techniques employed for market sizing; Exhibits192: Data synthesis; Exhibits193: 360 degree market analysis; Exhibits194: List of abbreviations